Dalrada discloses loan defaults and $500K cure demand

Dalrada Technology Group, Inc. reported that it and certain subsidiaries received a notice of default on multiple credit facilities from Nautilus entities on April 24, 2026.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

8-K

Rhea-AI Filing Summary

Dalrada Technology Group, Inc. reported that it and certain subsidiaries received a notice of default on multiple credit facilities from Nautilus entities on April 24, 2026. The lender cites missed required payments and is demanding a $500,000 cure payment by May 1, 2026.

If the cure is not made, the lender may accelerate the loan balances and begin enforcement actions under the term loan and factoring agreements. Dalrada is reviewing the notice and plans to discuss potential resolutions, but states there is no assurance the defaults will be cured or that acceleration and enforcement will be avoided.

Positive

None.

Negative

Notice of default and cure demand: Dalrada and certain subsidiaries are in default under multiple loan and security agreements, with the lender demanding a $500,000 cure by May 1, 2026 and reserving the right to accelerate the loans and pursue enforcement actions.

Insights

Loan defaults and cure demand signal elevated credit risk for Dalrada.

Dalrada Technology Group has received a formal notice of default on several loan and security agreements, including a term loan and a factoring facility. The lender is demanding a $500,000 cure payment by May 1, 2026 to address missed required payments.

If the cure is not paid, the lender can accelerate the outstanding loan balances and pursue enforcement actions under the existing security agreements. This could include exercising collateral rights, which may pressure liquidity and operations across Dalrada and its Genefic subsidiaries that are party to these agreements.

The company indicates it intends to engage with the lender to resolve obligations but explicitly notes there is no assurance that defaults will be cured or that acceleration will be avoided. Future disclosures about any negotiated amendments, waivers, refinancings, or enforcement actions will shape how this credit situation affects Dalrada’s financial flexibility.

8-K Event Classification

Item 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation

1 item

Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation Financial

An event triggered acceleration or increase of an existing financial obligation, such as a debt covenant breach.

Key Figures

Cure payment demanded: $500,000 Term Loan Agreement date: July 25, 2023 Genefic loan dates: Feb 22, 2024; Mar 22, 2024; Apr 5, 2024; Apr 18, 2024 +3 more

6 metrics

Cure payment demanded $500,000 Payment required by May 1, 2026 to address defaults

Term Loan Agreement date July 25, 2023 Term Loan Agreement subject to default notice

Genefic loan dates Feb 22, 2024; Mar 22, 2024; Apr 5, 2024; Apr 18, 2024 Loan and Security Agreements affected by default

Factoring Agreement date February 25, 2025 Loan and Security Agreement with Factoring Lender in default

Default notice date April 24, 2026 Date lender issued notice of default

Cure deadline May 1, 2026 Deadline to pay $500,000 cure before acceleration risk

Key Terms

notice of default, Term Loan Agreement, Loan and Security Agreement, Factoring Lender, +2 more

6 terms

notice of default financial

"received a notice of default from counsel to Nautilus Parent Holdings, LLC"

Term Loan Agreement financial

"defaults under (i) the Term Loan Agreement dated July 25, 2023"

A term loan agreement is a formal contract in which a borrower receives a fixed amount of money from a lender and agrees to repay it over a set period with interest, much like a mortgage or car loan for a business. It matters to investors because the scheduled repayments, interest cost and any lender-imposed rules affect a company’s cash flow, financial flexibility and creditworthiness, which can change risk and share value.

Loan and Security Agreement financial

"four separate Loan and Security Agreements dated February 22, 2024, March 22, 2024"

A loan and security agreement is a legal contract that sets out the amount, repayment schedule, interest and the rules a borrower must follow, and it names specific assets a lender can claim if the borrower fails to pay. Think of it like a mortgage or car loan where the lender holds a claim on collateral until the debt is repaid. Investors care because it determines a company’s repayment priorities, borrowing costs, operational limits and how easily creditors can seize assets in distress, all of which affect equity value and credit risk.

Factoring Lender financial

"Genefic, Inc., the Company, and the Factoring Lender"

accelerate the respective balances financial

"the Lender will accelerate the respective balances of the Loans"

enforcement actions financial

"immediately commence enforcement actions under the Loan Documents"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Dalrada Technology Group, Inc. (DHTI) disclose in this 8-K filing?

Dalrada disclosed it and certain subsidiaries received a notice of default from its term and factoring lenders. The lenders cite missed required payments and are demanding a $500,000 cure payment by May 1, 2026, with potential loan acceleration and enforcement actions if unpaid.

Why is Dalrada Technology Group, Inc. (DHTI) in default under its loan agreements?

The lenders state Dalrada and related borrowers failed to make required payments under a term loan agreement and several loan and security agreements. This non-payment triggered defaults across the loan documents, prompting the formal notice of default sent on April 24, 2026 by lender counsel.

How much must Dalrada Technology Group, Inc. (DHTI) pay to cure the default?

The lenders are demanding a cure payment of $500,000 no later than May 1, 2026. This amount is intended to address the cited payment defaults under the various term loan and loan and security agreements referenced in the notice of default.

What happens if Dalrada Technology Group, Inc. (DHTI) does not make the $500,000 cure payment?

If the $500,000 cure payment is not made by May 1, 2026, the lenders state they will accelerate the respective loan balances and immediately commence enforcement actions under the loan documents, while reserving all rights and not waiving any existing or future defaults.

Which agreements are affected by Dalrada Technology Group, Inc. (DHTI)’s loan defaults?

The notice of default covers the Term Loan Agreement dated July 25, 2023, four separate Loan and Security Agreements dated in early 2024 involving Genefic Specialty RX, Inc., and a Loan and Security Agreement dated February 25, 2025 among Genefic, Inc., Dalrada, and the factoring lender.

How is Dalrada Technology Group, Inc. (DHTI) responding to the loan default notice?

Dalrada states it is reviewing the notice of default and intends to engage in discussions with the lenders to seek a resolution of the outstanding obligations. However, the company cautions there can be no assurance that the defaults will be cured or that acceleration and enforcement will be avoided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/30/2026 - 07:44 PM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

April 24, 2026

Date of Report (Date of earliest event reported)

Dalrada Technology Group, Inc.

(Exact name of registrant as specified in its charter)

wyoming	000-12641	38-3713274
(State or other jurisdiction of	(Commission File	(IRS Employer Identification No.)
incorporation)	Number)

600 La Terraza Blvd., Escondido, California		92025
(Address of principal executive offices)		(Zip Code)

(858) 283-1253

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

On April 24, 2026, Dalrada Technology Group, Inc. (the “Company”), together with certain of its subsidiaries, received a notice of default from counsel to Nautilus Parent Holdings, LLC (as successor-in-interest to OnPoint LTB, LLC, the “Term Lender”) and Nautilus Funding Solutions, LLC – Series XIII (the “Factoring Lender,” and collectively with the Term Lender, the “Lender”). The notice declares defaults under (i) the Term Loan Agreement dated July 25, 2023 (and related promissory note, guaranty by the Company, security agreements, warrant, and all amendments), (ii) four separate Loan and Security Agreements dated February 22, 2024, March 22, 2024, April 5, 2024, and April 18, 2024 between Genefic Specialty RX, Inc. and the Term Lender, and (iii) the Loan and Security Agreement dated February 25, 2025 among Genefic, Inc., the Company, and the Factoring Lender (collectively, the “Loan Documents”). The Lender attributes the defaults to the borrowers’ failure to make required payments under the Loan Documents.

The Lender demands a cure payment of $500,000 no later than May 1, 2026. The notice states that, if the cure payment is not made, the Lender will accelerate the respective balances of the Loans and immediately commence enforcement actions under the Loan Documents. The notice further reserves all rights and remedies of the Lender and expressly states that it does not waive any existing or future defaults.

The Company is reviewing the notice and intends to engage in discussions with the Lender regarding resolution of the outstanding obligations. There can be no assurance that the defaults will be cured, that the Loans will not be accelerated, or that enforcement actions will not be pursued.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dalrada Technology Group, Inc.

By: /s/ Brian Bonar

Name: Brian Bonar

Title: Chief Executive Officer and Chairman

Date: April 30, 2026

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Dalrada discloses loan defaults and $500K cure demand